Topic Hub
25 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 25 of 25 clinical reviews.
A physician-reviewed deep dive comparing compounded tadalafil (2.5 to 20 mg) with branded Cialis and generic FDA-approved tablets, covering pharmacokinetics, dosing, safety, cost, and regulatory status.
Read clinical reviewA physician-reviewed guide covering how and when to safely restart tadalafil 2.5 to 20 mg after acute illness, including dose titration, drug interactions, cardiovascular screening, and evidence-based restart protocols.
Read clinical reviewDoes generic tadalafil (2.5 to 20 mg) affect appetite or food cravings? A physician-reviewed deep dive into the pharmacology, clinical trial data, and practical guidance for patients and prescribers.
Read clinical reviewA physician-reviewed, primary-literature guide to tadalafil 2.5 to 20 mg safety, dosing adjustments, and drug interactions for patients with autoimmune conditions including lupus, RA, vasculitis, and inflammatory bowel disease.
Read clinical reviewA clinician-reviewed deep dive into how tadalafil 2.5 to 20 mg affects bone mineral density, fracture risk, and skeletal metabolism. Covers PDE5 inhibitor mechanisms, key trials, and practical prescribing guidance.
Read clinical reviewA comprehensive MD/PharmD-level review of tadalafil 2.5 to 20 mg and cancer risk signals, covering PDE5-inhibitor biology, epidemiological data, bladder and prostate cancer considerations, and current clinical guidance for prescribers.
Read clinical reviewA physician-level review of tadalafil's long-term cardiovascular effects, covering hemodynamics, heart failure data, drug interactions, and safety in men with ED and BPH.
Read clinical reviewA physician-reviewed deep dive into tadalafil's effects on cognitive function, cerebral blood flow, and neuroinflammation. Covers doses 2.5 to 20 mg, key clinical trials, and practical prescribing guidance.
Read clinical reviewA physician-level review of tadalafil 2.5 to 20 mg across erectile dysfunction and BPH indications, with every major trial graded by GRADE certainty and practical dosing guidance.
Read clinical reviewA physician-reviewed deep dive into tadalafil's effects on hair and skin, covering the pharmacology, clinical trial data, and practical guidance for patients on 2.5 to 20 mg daily or on-demand dosing.
Read clinical reviewA physician-reviewed deep dive into how tadalafil 2.5 to 20 mg affects liver function, including pharmacokinetics, hepatic metabolism, clinical trial safety data, and dosing guidance for patients with liver disease.
Read clinical reviewA clinical deep-dive into how tadalafil 2.5 to 20 mg affects mental health, mood, anxiety, and depression, covering trial data, mechanisms, and prescribing considerations.
Read clinical reviewHow tadalafil 2.5 to 20 mg is absorbed, metabolized via CYP3A4, and cleared, plus the emerging evidence linking PDE5 inhibition to thermogenesis, mitochondrial biogenesis, and metabolic outcomes in humans.
Read clinical reviewA physician-reviewed guide to how tadalafil 2.5 to 20 mg supports skeletal muscle preservation, the mechanisms involved, dosing considerations, and how to combine it with exercise and hormone therapy for maximum benefit.
Read clinical reviewWhy tadalafil stops working, how to identify the cause, and the clinical steps to restore response. MD/PharmD-level guidance on dose optimization, timing errors, drug interactions, and when to escalate.
Read clinical reviewA physician-reviewed guide to using generic tadalafil (2.5 to 20 mg) after bariatric surgery, covering pharmacokinetic changes, dose selection, drug interactions, and monitoring protocols for ED and BPH indications.
Read clinical reviewComplete clinical guide to the tadalafil pre-surgery hold window: how long to stop tadalafil before any procedure, why the pharmacology demands it, and how to manage BPH/ED patients perioperatively.
Read clinical reviewA physician-reviewed guide on what happens when you stop tadalafil (generic, 2.5 to 20 mg), covering rebound ED, BPH symptom return, cardiovascular considerations, and how to taper safely based on current clinical evidence.
Read clinical reviewDoes tadalafil protect the kidneys or harm them? This MD/PharmD-level review covers the pharmacology, clinical trial data, dosing in CKD, and safety profile of generic tadalafil 2.5 to 20 mg for erectile dysfunction and BPH.
Read clinical reviewA clinician-level guide to how temperature, humidity, altitude, and seasonal health patterns affect tadalafil 2.5 to 20 mg dosing, storage, and efficacy for ED and BPH-LUTS.
Read clinical reviewA physician-reviewed guide to how tadalafil 2.5 to 20 mg affects erectile function, LUTS/BPH symptoms, and libido. Covers PDE5 mechanism, dosing schedules, key trial data, and safety thresholds.
Read clinical reviewHow tadalafil 2.5 to 20 mg affects sleep architecture, nocturnal erections, sleep apnea, and overnight PDE5 inhibition. MD-level review with primary literature citations.
Read clinical reviewA clinician-reviewed guide to tadalafil dosing during long-haul travel, jet lag, and timezone shifts, covering daily and as-needed regimens for ED and BPH.
Read clinical reviewA clinician-reviewed, week-by-week guide to tadalafil 2.5 to 20 mg covering onset, dose titration, side effects, and what changes to expect across the first 30 days of therapy.
Read clinical reviewA physician-reviewed deep dive into tadalafil 2.5 to 20 mg dosing strategies, including daily low-dose microdosing for ED, BPH/LUTS, and cardiopulmonary uses. Primary-literature citations throughout.
Read clinical review